Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
2.57
AUD
1.58%
Market Cap:
AU$208.8m
Relative Value
The Relative Value of one
MYX
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 2.57 AUD,
Mayne Pharma Group Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MYX Relative Value
HIDDEN
Multiples Across Competitors
MYX Competitors Multiples
Mayne Pharma Group Ltd Competitors
Mayne Pharma Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Mayne Pharma Group Ltd
ASX:MYX
|
208.8m AUD | 0.5 | -2.2 | -1.5 | -1.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
966.3B USD | 14.8 | 46.8 | 31.6 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
290.5B CHF | 4.7 | 30.9 | 13 | 15.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
245.6B CHF | 5.6 | 22.7 | 14 | 18 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP | 5.4 | 30.8 | 17.1 | 24.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.1B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123B USD | 2.6 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
